Leadership

Silvia Taylor is the Executive Vice President and Chief Corporate Affairs and Advocacy Officer at Novavax. In her capacity, Ms. Taylor oversees both external and internal communications, government affairs, public policy, patient advocacy, corporate reputation, global corporate digital experience and engagement, and corporate responsibility. She is also responsible for government and nongovernmental organization contracting and alliances. With a career spanning over 25 years in the pharmaceutical, biotech, and public health sectors, she brings a wealth of experience in commercial, corporate, and financial communications to her leadership role. Ms. Taylor's diverse background includes marketing blockbuster and specialty pharmaceuticals, product launches, capital raising, and holding key positions in global investor relations and corporate affairs at prominent biopharmaceutical firms such as Pfizer, MedImmune, Sucampo, and Autolus.

Originally from Argentina, Ms. Taylor holds a Master of Business Administration degree from Columbia University and a Bachelor of Arts in foreign affairs from the University of Virginia. She serves on the Boards of Directors for the Maryland Technology Council and the Biotechnology Innovation Organization (BIO), for which she also co-chairs the BIO Vaccine Policy Steering Committee.